• nor-Binaltorphimine Dihydrochloride: Gold-Standard κ-Opio...

  2026-02-18

  nor-Binaltorphimine dihydrochloride is a highly selective κ-opioid receptor antagonist widely used in opioid receptor pharmacology and pain modulation research. Its exceptional specificity enables precise interrogation of κ-opioid signaling pathways. APExBIO's B6269 product offers researchers a robust, high-purity tool for dissecting opioid receptor-mediated mechanisms.

• HyperFluor™ 488 Goat Anti-Mouse IgG: High-Sensitivity Sec...

  2026-02-17

  HyperFluor™ 488 Goat Anti-Mouse IgG (H+L) Antibody is an affinity-purified, fluorescently labeled secondary antibody optimized for sensitive mouse IgG detection in immunofluorescence and immunoassays. Its high specificity and proprietary dye conjugation deliver robust signal amplification, supporting reproducible results in flow cytometry, western blotting, and immunohistochemistry workflows.

• Harnessing Ademetionine (S-Adenosylmethionine; SAMe) for ...

  2026-02-17

  This thought-leadership article explores S-Adenosylmethionine (SAMe, Ademetionine) as a universal methyl donor at the intersection of mechanistic neurobiology and translational research strategy. By integrating foundational clinical evidence, case studies, and experimental best practices, we illuminate the path from methylation biology to next-generation CNS disorder therapeutics—outlining how high-purity SAM (APExBIO SKU B3513) enables reproducible, impactful research and clinical innovation.

• EZ Cap™ EGFP mRNA (5-moUTP): Capped mRNA for High-Fidelit...

  2026-02-16

  EZ Cap™ EGFP mRNA (5-moUTP) enables robust, low-immunogenic reporter expression in cellular and in vivo systems, leveraging a Cap 1 structure and 5-moUTP modification for enhanced translation efficiency and immune suppression. This mRNA tool is optimal for translational research requiring precise gene expression, stability, and fluorescence readout.

• DRB (5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole): Prec...

  2026-02-15

  DRB (5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole) is a highly specific transcriptional elongation inhibitor and CDK inhibitor, used to interrogate HIV transcription and cell fate regulation. Its mechanistic precision, validated IC50 ranges, and integration in translational studies make it a cornerstone for research on RNA polymerase II modulation and antiviral strategies. APExBIO supplies DRB (SKU C4798) as a high-purity reagent for leading-edge investigations.

• 4-Phenylbutyric Acid: A Chemical Chaperone for ER Stress ...

  2026-02-14

  4-Phenylbutyric acid (4-PBA) stands out as a high-purity chemical chaperone for ER stress, driving reproducible research in apoptosis, autophagy, and inflammation. APExBIO’s 4-PBA enables robust modulation of endoplasmic reticulum stress pathways, empowering advanced experimental design and troubleshooting in disease models.

• H 89 2HCl: Potent PKA Inhibitor for Precise cAMP/PKA Sign...

  2026-02-14

  H 89 2HCl is a potent and selective protein kinase A inhibitor that enables precise dissection of cAMP-dependent signaling pathways in cellular and animal models. With nanomolar potency and well-characterized selectivity, this compound supports advanced research in signaling, neurodegeneration, and bone biology. APExBIO supplies H 89 2HCl (SKU: B2190) for research use, offering validated workflows and detailed application guidelines.

• CCCP and Mitochondrial Dysfunction: Advanced Insights for...

  2026-02-13

  Explore how CCCP (carbonyl cyanide m-chlorophenyl hydrazine), a premier uncoupler of oxidative phosphorylation, is redefining mitochondrial research. This guide reveals advanced applications, mechanistic insights, and translational opportunities that set CCCP research apart.

• Optimizing ECM and Cell Assays with GM 6001 (Galardin) Br...

  2026-02-13

  This article provides a scenario-driven guide for biomedical researchers and lab scientists to overcome common experimental challenges in extracellular matrix (ECM) and cell-based assays using GM 6001 (Galardin) Broad Spectrum Matrix Metalloproteinase Inhibitor (SKU A4050). Drawing from peer-reviewed data and validated lab workflows, the discussion emphasizes the compound’s reproducibility, specificity, and practical integration into protocols for cell viability, proliferation, and neurodegeneration studies.

• DiscoveryProbe™ Bioactive Compound Library Plus: Benchmar...

  2026-02-12

  The DiscoveryProbe™ Bioactive Compound Library Plus enables robust, reproducible high-throughput screening across apoptosis, cancer research, and pathway analysis. This bioactive compound library offers 5,072 rigorously validated, cell-permeable compounds, supporting diverse biomedical applications and mechanistic studies.

• Carfilzomib (PR-171): Unveiling Proteasome Inhibition for...

  2026-02-12

  Discover the advanced mechanisms of Carfilzomib (PR-171), an irreversible proteasome inhibitor, and its unique role in driving multi-modal cell death and radiosensitization in cancer biology. This in-depth analysis highlights new mechanistic insights, comparative strategies, and future directions for proteasome inhibition in oncology research.

• Trametinib (GSK1120212): Precision MEK1/2 Inhibitor for O...

  2026-02-11

  Trametinib (GSK1120212) is a potent, highly specific MEK1/2 inhibitor used to dissect the MAPK/ERK pathway in cancer research. Its ATP-noncompetitive mechanism enables robust, dose-dependent cell cycle arrest and apoptosis, particularly in B-RAF mutated models. This article synthesizes current benchmarks, solubility parameters, and workflow integration for reproducible experimental outcomes.

• Scenario-Driven Solutions with MK-2206 dihydrochloride (S...

  2026-02-11

  This article addresses real laboratory challenges in cell viability, proliferation, and apoptosis assays by presenting scenario-based solutions grounded in the use of MK-2206 dihydrochloride (SKU A3010). Biomedical researchers and lab technicians will discover evidence-backed guidance for optimal protocol design, data interpretation, and reliable product selection—maximizing assay reproducibility and translational insight.

• Calpain Inhibitor I (ALLN): Potent Calpain and Cathepsin ...

  2026-02-10

  Calpain Inhibitor I (ALLN) is a potent, cell-permeable inhibitor targeting calpain and cathepsin proteases, widely used in apoptosis assays and ischemia-reperfusion injury models. Its robust selectivity profile and compatibility with advanced phenotypic workflows position ALLN as a gold standard for dissecting protease-driven pathways in cancer and inflammation research.

• BX795: Potent ATP-Competitive PDK1 Inhibitor for Targeted...

  2026-02-10

  BX795 is a highly selective ATP-competitive PDK1 inhibitor with nanomolar potency, enabling precise dissection of PI3K/Akt/mTOR and innate immune signaling pathways. Its dual inhibition of TBK1 and IKKε positions it as a robust tool for cancer, antiviral, and inflammation research. Supplied by APExBIO, BX795 delivers reproducible results in vitro with clear mechanistic benchmarks.

456 records 28/31 page Previous Next First page 上5页 2627282930 下5页 Last page